FoodApr 8, 2026
Super World Trading MEI HEONG YUEN TANGERINE FLAVOR ROASTED PEANUTS recall — FDA H-0641-2026
Products contain cyclamates (banned sweetener)
Class IIIFDA: TerminatedSuper World Trading Inc.
April 2026 recalls — page 14
These records include useful source details for the selected month.
FoodApr 8, 2026
Imu-Tek Colostrum-5 120 Capsules recall — FDA H-0660-2026
Product is potentially under-processed.
Class IIFDA: CompletedImu-Tek Animal Health, Incorporated
FoodApr 8, 2026
JFE FRANCHISING " Dumpling Party Tray recall — FDA H-0639-2026
Foreign Object (Glass)
Class IIFDA: OngoingJFE FRANCHISING INC
FoodApr 8, 2026
JFE FRANCHISING " Dumpling Vegetable 4.5 oz 011110658067 " Loaded Dumpling recall — FDA H-0638-2026
Foreign Object (Glass)
Class IIFDA: OngoingJFE FRANCHISING INC
DrugApr 8, 2026
K.C. Pharmaceuticals STERILE EYE DROPS SOOTHING TEARS recall — FDA D-0415-2026
Lack of Assurance of Sterility
Class IIFDA: OngoingK.C. Pharmaceuticals, Inc
DrugApr 8, 2026
QUALITY CHOICE EYE DROPS IRRITATION RELIEF Sterile EYE DROPS AC recall — FDA D-0409-2026
Lack of Assurance of Sterility
Class IIFDA: OngoingK.C. Pharmaceuticals, Inc
DrugApr 8, 2026
QUALITY CHOICE MOISTURIZING RELIEF EYE DROPS EYE DROPS Advanced Relief recall — FDA D-0410-2026
Lack of Assurance of Sterility
Class IIFDA: OngoingK.C. Pharmaceuticals, Inc
DrugApr 8, 2026
Prazosin Hydrochloride Capsules, USP, 5mg, 100-count bottle recall — FDA D-0421-2026
cGMP deviation: detection of Nitrosamine Drug Substance-Related Impurities, N-nitroso-prazosin impurity C (NNP) above acceptable limits.
Class IIFDA: OngoingAppco Pharma LLC
DrugApr 8, 2026
Bromfenac Ophthalmic Solution 0.07%, 3 ml recall — FDA 98647
Failed Impurities/Degradation Specifications: out of specification at the time of testing i.e. 20th month stability testing.
Class IIFDA: OngoingALEMBIC PHARMACEUTICALS, INC.
DrugApr 8, 2026
LEADER EYE DROPS REDNESS RELIEF Sterile EYE DROPS REDNESS LUBRICANT recall — FDA D-0414-2026
Lack of Assurance of Sterility
Class IIFDA: OngoingK.C. Pharmaceuticals, Inc
DrugApr 8, 2026
ARTIFICIAL TEARS Dry Eye Relief Eye Drops recall — FDA D-0411-2026
Lack of Assurance of Sterility
Class IIFDA: OngoingK.C. Pharmaceuticals, Inc
DrugApr 8, 2026
GOODSENSE EYE DROPS ORIGINAL FORMULA Sterile Eye Drops ORIGINAL FORMULA recall — FDA D-0413-2026
Lack of Assurance of Sterility
Class IIFDA: OngoingK.C. Pharmaceuticals, Inc
DrugApr 8, 2026
LEADER ULTRA LUBRICATING EYE DROPS Ultra Lubricating Eye Drops recall — FDA D-0412-2026
Lack of Assurance of Sterility
Class IIFDA: OngoingK.C. Pharmaceuticals, Inc
DrugApr 8, 2026
LEADER ARTIFICIAL TEARS 15 ML Artificial Tears Sterile Lubricant Eye Drops recall — FDA D-0416-2026
Lack of Assurance of Sterility
Class IIFDA: OngoingK.C. Pharmaceuticals, Inc
DrugApr 8, 2026
Magnesium Sulfate in Water for Injection, 4g/100 mL (40mg/mL) IV bag recall — FDA D-0478-2026
Product mix up: a foil pouch labeled "Magnesium Sulfate in Water for Injection, 4 g/100 mL" actually contained an IV bag of Tranexamic Acid instead.
Class IFDA: OngoingAmneal Pharmaceuticals, LLC
DrugApr 8, 2026
Prazosin Hydrochloride Capsules, USP, 2mg, 100-count bottle recall — FDA D-0420-2026
cGMP deviation: detection of Nitrosamine Drug Substance-Related Impurities, N-nitroso-prazosin impurity C (NNP) above acceptable limits.
Class IIFDA: OngoingAppco Pharma LLC
DrugApr 8, 2026
traMADol Hydrochloride Tablets, USP, 50 mg, 500-count bottles recall — FDA D-0408-2026
Failed Impurities/Degradation Specifications: N-nitroso-desmethyl-tramadol impurity (NDSRI) was found out of the specification at 24-month stability interval during Long term stability…
Class IIFDA: OngoingAmneal Pharmaceuticals, LLC
DrugApr 8, 2026
Prazosin Hydrochloride Capsules, USP, 1mg, 100-count bottle recall — FDA D-0419-2026
cGMP deviation: detection of Nitrosamine Drug Substance-Related Impurities, N-nitroso-prazosin impurity C (NNP) above acceptable limits.
Class IIFDA: OngoingAppco Pharma LLC
VehicleApr 6, 2026
Hyundai Motor anchorage recall — NHTSA campaign 26V218000
Hyundai Motor America (Hyundai) is recalling certain 2023-2025 Hyundai Ioniq 6, 2023-2026 Genesis G90, 2024-2026 Hyundai Santa Fe, and Hyundai Santa Fe Hybrid vehicles. The driver and…
anchorageHyundai Motor America
VehicleApr 2, 2026
Chevrolet Malibu camera recall — NHTSA campaign 26V212000
General Motors, LLC (GM) is recalling certain 2023-2025 Chevrolet Malibu vehicles. The rearview camera screen may display a distorted or blank image.
cameraGeneral Motors, LLC
VehicleApr 1, 2026
Q3 sunroof recall — NHTSA campaign 26V209000
Volkswagen Group of America, Inc. (Audi) is recalling certain 2026 Q3 vehicles. Incorrect software may allow remote sunroof closing from a distance that prevents the operator from clearly…
sunroofVolkswagen Group of America, Inc.
Medical DeviceApr 1, 2026
Philips Respironics Trilogy Evo, Software Version 1.05.15.00 recall — FDA Z-1614-2026
Using non-pneumatic nebulizers with Trilogy Evo Platform ventilators may result in a discrepancy between the set tidal volume and the tidal volume received by the patient.
Class IFDA: OngoingPhilips Respironics, Inc.
Medical DeviceApr 1, 2026
Medline Industries Puracol and Puracol Plus Collagen Wound Dressings: MSC8522 recall — FDA Z-1650-2026
Elevated endotoxin levels identified in affected lots. Issue may elicit strong inflammatory response if used, including local tissue irritation, delayed wound healing, or systemic effects…
Class IIFDA: OngoingMedline Industries, LP
Medical DeviceApr 1, 2026
I.T.S. GmbH Pelvic Reconstruction System (PRS) with the below descriptions and corresponding recall — FDA Z-1600-2026
Updated MRI safety testing demonstrates higher RF-induced temperature increases under certain MRI conditions than previously reflected in the Instructions for Use (IFU).
Class IIFDA: OngoingI.T.S. GmbH
How to use this monthly recall archive
Use this page to compare the recalls reported during the month, then open an individual record for the exact reason, classification, company, remedy or distribution information available from the official source. Monthly counts are descriptive, not a safety rating.